gene_symbol
UNKNOWN
binding_type
antigen recognition
cytotoxicity
NO
cytotoxicity_type
INDIRECT
cytotoxicity_mechanism
CD3+ T cells are not killed; the drug engages CD3 to activate T cells, which then kill CD20+ tumor cells via perforin/granzyme after immunologic synapse formation.
enzyme_product
Off
epitope
Off
variant
Off
isoform
Off
hla_specific
Off
gated
Off
other_modifier
T-cell receptor/CD3 complex component
trial_id_tar_ref
drug_id_tar_ref
disease_id_tar_ref
nct_id_tar_ref
NCT06414148
disease_id_num_tar_ref
4057
drug_id_num_tar_ref
10939